Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy
Related Posts
Duberstein ZT, Murphy H, Wu Q, Meng Y, Wang C, Smith R, Salafia C, Chowdhury SF, Barrett E, Scheible K, Qiu X, O'Connor TG. Do[...]
Wojcik G, Arvanitis M, Haberlen S, Kim EY, Kim H, Nam K, Feinstein MJ, Wolinsky S, Margolick JB, Budoff M, Magnani JW, Duggal P, Post[...]
Tantisattamo E, Rattanasompattikul M, Traitanon O, Eguchi N, Ichii H, Kantachuvesiri S, Kalantar-Zadeh K. Enhancing accuracy and adherence in blood pressure monitoring in living kidney[...]